12 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

CARDIAC PHASED ARRAY COIL

FDA 510(k)
FDA Class 2 ·Radiology

Powder Free Nitrile Examination Glove

FDA 510(k)
FDA Class 1 ·General Hospital

SYNTHES VECTRA-ONE SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

ENDOPATH ENDOSCOPIC MULTIFEED STAPLER

FDA Adverse Event
Malfunction ·ETHICON ENDO-SURGERY, INC.·Product code GAG·April 14, 1997

UNK - SCREW

FDA Adverse Event
Malfunction ·SYNTHES (USA)·Product code KWQ·July 26, 2011

UNK - SCREW

FDA Adverse Event
Malfunction ·SYNTHES (USA)·Product code KWQ·July 26, 2011

UNK - SCREW

FDA Adverse Event
Malfunction ·SYNTHES (USA)·Product code KWA·July 26, 2011

UNK - SCREW

FDA Adverse Event
Malfunction ·SYNTHES (USA)·Product code KWQ·July 26, 2011

ACCU-CHEK SPIRIT CARTRIDGE

FDA Adverse Event
Malfunction ·ROCHE HEALTH SOLUTIONS INC.·Product code LZG·January 30, 2013

ACCU-CHEK ® AVIVA TEST STRIPS

FDA Adverse Event
Malfunction ·ROCHE DIAGNOSTICS·Product code LFR·January 27, 2011

UNKNOWN DEPUY SZ 3 RP TIBIAL TRAY

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS, INC. 1818910·Product code JWH·July 31, 2014

Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017